We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+46.09%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$5.02B
AUM Growth
+$1.49B
Cap. Flow
+$1.13B
Cap. Flow %
22.53%
Top 10 Hldgs %
83.43%
Holding
370
New
151
Increased
34
Reduced
34
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 34.73%
2 Consumer Discretionary 6.37%
3 Communication Services 3.71%
4 Financials 2.11%
5 Industrials 0.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RENE
201
DELISTED
Cartesian Growth Corp II
RENE
$142K ﹤0.01%
+1,897,500
New +$22M
VET icon
202
Vermilion Energy
VET
$1.59B
$137K ﹤0.01%
+14,610
New +$142K
PEB icon
203
Pebblebrook Hotel Trust
PEB
$2.2B
$136K ﹤0.01%
+10,000
New +$132K
HRTG icon
204
Heritage Insurance Holdings
HRTG
$905M
$133K ﹤0.01%
+11,000
New +$127K
ENVX icon
205
Enovix
ENVX
$866M
$130K ﹤0.01%
+13,714
New +$120K
BKD icon
206
Brookdale Senior Living
BKD
$3.67B
$126K ﹤0.01%
+25,000
New +$143K
PLBY icon
207
Playboy Inc
PLBY
$141M
$120K ﹤0.01%
82,008
NBP
208
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$119K ﹤0.01%
+140,100
New +$156K
EXK
209
Endeavour Silver
EXK
$2.29B
$111K ﹤0.01%
30,200
+7,500
+33% +$33.1K
BKD icon
210
CALL
Brookdale Senior Living
BKD
$3.67B
$101K ﹤0.01%
+20,000
New +$114K
HEPS
211
D-Market Electronic Services & Trading
HEPS
$1.06B
$97.6K ﹤0.01%
32,200
FULC icon
212
Fulcrum Therapeutics
FULC
$248M
$94K ﹤0.01%
+20,000
New +$73.8K
ANL
213
Adlai Nortye
ANL
$817M
$93.1K ﹤0.01%
40,310
-3,390
-8% -$7.69K
TRVI icon
214
Trevi Therapeutics
TRVI
$2.62B
$82K ﹤0.01%
+20,000
New +$64K
MCRB icon
215
Seres Therapeutics
MCRB
$46.5M
$79.6K ﹤0.01%
4,787
-9,241
-66% -$150K
QS icon
216
QuantumScape Corp
QS
$3.18B
$79.4K ﹤0.01%
+15,303
New +$80.3K
HPP
217
Hudson Pacific Properties
HPP
$765M
$72.5K ﹤0.01%
+3,571
New +$97.6K
ADVM
218
DELISTED
Adverum Biotechnologies
ADVM
$72.1K ﹤0.01%
15,446
MOB
219
Mobilicom Ltd
MOB
$59.5M
$69.3K ﹤0.01%
18,200
-54,400
-75% -$105K
ACIU icon
220
AC Immune
ACIU
$236M
$67.5K ﹤0.01%
+25,000
New +$78.1K
CARV
221
DELISTED
Carver Bancorp
CARV
$63.8K ﹤0.01%
+34,657
New +$60.9K
SKYX icon
222
SKYX Platforms
SKYX
$155M
$61.5K ﹤0.01%
53,010
SAND
223
DELISTED
Sandstorm Gold
SAND
$55.8K ﹤0.01%
+10,000
New +$58K
AMPS
224
DELISTED
Altus Power
AMPS
$52.9K ﹤0.01%
+13,000
New +$47.6K
SDSTW
225
Stardust Power Inc Warrant
SDSTW
$4.56M
$47.6K ﹤0.01%
+158,540
New +$54K

Similar funds

Cantor Fitzgerald's Q4 2024 Portfolio in Review

As of Q4 2024, Cantor Fitzgerald held 370 positions worth $5.02B, up 42% from $3.53B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Cantor Fitzgerald deployed $1.13B of net new capital in Q4 2024, opening 151 new positions and adding to 34 existing holdings. Its largest new stake was Strategy Inc: 3,580,131 shares worth $1.04B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $140M trimmed.

  • Cantor Fitzgerald's largest Q4 2024 buy was Strategy Inc: 3,580,131 shares worth $1.04B.
  • Cantor Fitzgerald added most to Advanced Micro Devices in Q4 2024, an estimated $171M increase.
  • Cantor Fitzgerald's biggest Q4 2024 reduction was Tesla, cutting an estimated $140M.
  • Cantor Fitzgerald fully exited AstraZeneca in Q4 2024, selling an estimated $11.5M.
  • Cantor Fitzgerald's ten largest holdings make up 83% of its $5.02B portfolio in Q4 2024.
  • Cantor Fitzgerald opened 151 new positions and closed 96 in Q4 2024.
  • Cantor Fitzgerald's portfolio value rose 42% quarter-over-quarter to $5.02B.

Based on Cantor Fitzgerald's 13F filing for Q4 2024, filed 14 Feb 2025.